124 related articles for article (PubMed ID: 34896245)
21. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
22. Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.
Ghiotto F; Marcatili P; Tenca C; Calevo MG; Yan XJ; Albesiano E; Bagnara D; Colombo M; Cutrona G; Chu CC; Morabito F; Bruno S; Ferrarini M; Tramontano A; Fais F; Chiorazzi N
Mol Med; 2011; 17(11-12):1188-95. PubMed ID: 21785810
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
Rigoni M; Riganti C; Vitale C; Griggio V; Campia I; Robino M; Foglietta M; Castella B; Sciancalepore P; Buondonno I; Drandi D; Ladetto M; Boccadoro M; Massaia M; Coscia M
Oncotarget; 2015 Oct; 6(30):29833-46. PubMed ID: 26284584
[TBL] [Abstract][Full Text] [Related]
24. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
25. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
[TBL] [Abstract][Full Text] [Related]
26. Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
Kriangkum J; Motz SN; Mack T; Beiggi S; Baigorri E; Kuppusamy H; Belch AR; Johnston JB; Pilarski LM
PLoS One; 2015; 10(9):e0137232. PubMed ID: 26353109
[TBL] [Abstract][Full Text] [Related]
27. Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.
Eagle GL; Zhuang J; Jenkins RE; Till KJ; Jithesh PV; Lin K; Johnson GG; Oates M; Park K; Kitteringham NR; Pettitt AR
Mol Cell Proteomics; 2015 Apr; 14(4):933-45. PubMed ID: 25645933
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
29. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract][Full Text] [Related]
30. Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.
Bright SA; Byrne AJ; Vandenberghe E; Browne PV; Mcelligott AM; Meegan MJ; Williams DC
Oncol Rep; 2019 May; 41(5):3127-3136. PubMed ID: 30896840
[TBL] [Abstract][Full Text] [Related]
31. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
32. LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.
Prieto D; Seija N; Uriepero A; Souto-Padron T; Oliver C; Irigoin V; Guillermo C; Navarrete MA; Inés Landoni A; Dighiero G; Gabus R; Giordano M; Oppezzo P
Br J Haematol; 2018 Aug; 182(4):521-525. PubMed ID: 29953583
[TBL] [Abstract][Full Text] [Related]
33. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.
Hoogeboom R; van Kessel KP; Hochstenbach F; Wormhoudt TA; Reinten RJ; Wagner K; Kater AP; Guikema JE; Bende RJ; van Noesel CJ
J Exp Med; 2013 Jan; 210(1):59-70. PubMed ID: 23296468
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
[TBL] [Abstract][Full Text] [Related]
35. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
[TBL] [Abstract][Full Text] [Related]
36. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases.
Parisi-Duchêne E; Mazurier I; Moskovtchenko P
Acta Haematol; 2006; 115(1-2):74-7. PubMed ID: 16424654
[TBL] [Abstract][Full Text] [Related]
37. Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia.
Rodriguez CM; Gilardoni MB; Remedi MM; Sastre D; Heller V; Pellizas CG; Donadio AC
Blood Cells Mol Dis; 2020 May; 82():102405. PubMed ID: 32007924
[TBL] [Abstract][Full Text] [Related]
38. Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia.
Mancikova V; Peschelova H; Kozlova V; Ledererova A; Ladungova A; Verner J; Loja T; Folber F; Mayer J; Pospisilova S; Smida M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217767
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
Dubovsky JA; Chappell DL; Harrington BK; Agrawal K; Andritsos LA; Flynn JM; Jones JA; Paulaitis ME; Bolon B; Johnson AJ; Byrd JC; Muthusamy N
Blood; 2013 Nov; 122(19):3308-16. PubMed ID: 24009233
[TBL] [Abstract][Full Text] [Related]
40. Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
Rozovski U; Keating MJ; Estrov Z
Acta Haematol; 2018; 140(1):51-54. PubMed ID: 30114695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
